CIK 0001799191
- Accelerated filer
- Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN STLNW DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843562323
- Phone
- +1 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Common stock Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-12 | Podnos Yale Chief Medical Officer | Grant or award | +11,359 | 11,359 | ||
| 2021-11-12 | Podnos Yale Chief Medical Officer | Grant or award | +17,039 | 17,039 | ||
| 2021-11-12 | Podnos Yale Chief Medical Officer | Grant or award · Stock Options (right to buy) | +77,916 | 77,916 | ||
| 2021-11-12 | Podnos Yale Chief Medical Officer | Grant or award · Stock Options (right to buy) | +68,208 | 68,208 | ||
| 2021-11-12 | Dalgleish Scott Chief Financial Officer | Grant or award | +47,566 | 47,566 | ||
| 2021-11-12 | Dalgleish Scott Chief Financial Officer | Grant or award | +71,350 | 118,916 | ||
| 2021-11-12 | Dalgleish Scott Chief Financial Officer | Grant or award · Stock Options (right to buy) | +261,023 | 261,023 | ||
| 2021-11-12 | Dalgleish Scott Chief Financial Officer | Grant or award · Stock Options (right to buy) | +350,876 | 350,876 | ||
| 2021-11-12 | SARIN RAVI YANG Director | Grant or award | +4,109,771 | 4,109,771 | ||
| 2021-11-12 | Virnich Daniel Chief Operating Officer | Grant or award | +78,094 | 78,094 | ||
| 2021-11-12 | Virnich Daniel Chief Operating Officer | Grant or award | +117,142 | 195,236 | ||
| 2021-11-12 | Virnich Daniel Chief Operating Officer | Grant or award · Stock Options (right to buy) | +426,603 | 426,603 | ||
| 2021-11-12 | Virnich Daniel Chief Operating Officer | Grant or award · Stock Options (right to buy) | +578,006 | 68,208 | ||
| 2021-11-12 | Kaushal Mohit Director | Conversion | +30,000 | 30,000 | ||
| 2021-11-12 | Kaushal Mohit Director | Returned to the company | −4,466 | 25,534 | ||
| 2021-11-12 | Kaushal Mohit Director | Conversion · Class B Common Stock | −30,000 | 0 | ||
| 2021-11-12 | Hively Brad Chief Executive Officer | Grant or award · Stock Options (right to buy) | +993,460 | |||
| 2021-11-12 | Hively Brad Chief Executive Officer | Grant or award · Stock Options (right to buy) | +823,971 | |||
| 2021-01-12 | Hively Brad Chief Executive Officer | Grant or award | +141,380 | 141,380 | ||
| 2021-01-12 | Hively Brad Chief Executive Officer | Grant or award | +212,070 | 212,070 |
Page 22 of 23 · 442 trades